Marvel Biosciences’ lead therapeutic candidate, MB-204 receives Japanese patent: Calgary, Alberta Thursday, February 5, 2026, 10:00 Hrs [IST] Marvel Biosciences Corporation and ...

CURE SYNGAP1, a 501(c)(3) organization, is proud to announce the award of a $25,000 grant to Dr. Àlex Bayés Puig, Group ...

Despite decades of research, scientists struggle to understand the mental health implications of DNA. Researchers were able ...

The Ban Ki-moon Foundation, Paris Brain Institute and Vascular Brain Health Institute empower the next generation of ...

DONGGUAN, GUANGDONG, CHINA, January 15, 2026 /EINPresswire.com/ -- As respiratory health challenges increase globally ...

The study, which assessed the pharmacokinetics, safety, tolerability and immunogenicity of AVT80 compared to Entyvio® in ...

Dr. Ronald C. Kessler of Harvard Medical School explores his leadership of global psychiatric epidemiology. His surveys across 30+ countries established frameworks that guide mental health policy ...

Explore the Q4 2025 Alger Weatherbie Specialized Growth Fund performance. Read about the top contributors and detractors in ...

SHANGHAI, Feb. 5, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and ...

Although the World Economic Forum Annual Meeting 2026 concluded, concerns voiced during the meeting about the world sliding toward a "ruleless" era continue to reverberate across the international ...

SHANGHAI, SHANGHAI, CHINA, January 20, 2026 /EINPresswire.com/ -- The global healthcare sector is witnessing a paradigm ...

Jaguar has received the initial $16M payment related to the company's recently executed US out-license agreement for ...